Inducible knockdown of MLL-AF4 significantly reduced ALL cells in the t(4;11)-positive PDX model tested, but not in a translocation-negative sample, proving a tumor maintaining role of MLL-AF4 in established patient tumors in vivo (Figs. 3b and S3a). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.